Microbiology & Infectious Diseases

New evidence suggests that a 7-day course of antibiotics is as effective as a 14-day regimen for most patients with Gram-negative bloodstream infections.

New findings highlight the potential of once-yearly intramuscular lenacapavir for PrEP, offering a long-acting alternative that could reduce barriers to HIV prevention.

The ECDC reports an alarming 10% rise in childhood tuberculosis cases across Europe, stressing the urgent need for enhanced prevention, diagnosis, and treatment.

A first-in-human study evaluating a novel long-acting injectable antiretroviral therapy has provided promising early results on its safety and pharmacokinetics.

COVID-19 caused a significant decline in life expectancy and years of life lost across 18 European countries from 2020–2022.

The new CRISPR-Cascade assay eliminates the need for nucleic acid amplification, enabling highly sensitive detection of pathogens within minutes.

A groundbreaking Phase IIa HIV cure study in South Africa has demonstrated the safety and potential efficacy of a novel therapeutic regimen in women with HIV.

Measles cases in the EU/EEA have risen dramatically over the past year, with numbers far exceeding those reported in 2023.